Volume 84, Issue 1, Pages 34-44 (July 2013) Glomerular diseases seen with cancer and chemotherapy: a narrative review Kenar D. Jhaveri, Hitesh H. Shah, Kellie Calderon, Eric S. Campenot, Jai Radhakrishnan Kidney International Volume 84, Issue 1, Pages 34-44 (July 2013) DOI: 10.1038/ki.2012.484 Copyright © 2013 International Society of Nephrology Terms and Conditions
Figure 1 Membranous glomerulopathy (original magnification × 600, trichrome stain). Glomerulus displaying membranous features with fuchsinophilic subepithelial deposits. The patient has a history of lung cancer with multiple enlarged hilar lymph nodes. Kidney International 2013 84, 34-44DOI: (10.1038/ki.2012.484) Copyright © 2013 International Society of Nephrology Terms and Conditions
Figure 2 Original magnification × 600, hematoxylin and eosin (H&E) stain. Glomerulus displaying membranoproliferative features with accentuated lobularity, mesangial proliferation, and endocapillary proliferation. The patient has a history of chronic lymphocytic leukemia. Kidney International 2013 84, 34-44DOI: (10.1038/ki.2012.484) Copyright © 2013 International Society of Nephrology Terms and Conditions
Figure 3 Collapsing focal segmental glomerulosclerosis (FSGS; original magnification × 600, Jones methenamine silver (JMS) stain). Collapsing FSGS in a patient who has a history of malignant melanoma and is being treated with interferon therapy. Kidney International 2013 84, 34-44DOI: (10.1038/ki.2012.484) Copyright © 2013 International Society of Nephrology Terms and Conditions
Figure 4 Thrombotic microangiopathy (TMA; original magnification × 600, Jones methenamine silver (JMS) stain). Glomerulus displaying changes of acute thrombotic microangiopathy with red blood cell congestion, intracapillary fibrin thrombi, and mesangiolysis. The patient has a history of pancreatic cancer with liver metastasis and is being treated with tyrosine kinase inhibitors (sorafenib and erlotinib). Kidney International 2013 84, 34-44DOI: (10.1038/ki.2012.484) Copyright © 2013 International Society of Nephrology Terms and Conditions